4/A//SEC Filing
Kiley Alison 4/A
Accession 0001181431-10-054757
CIK 0001338042other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 3:47 PM ET
Size
6.5 KB
Accession
0001181431-10-054757
Insider Transaction Report
Form 4/AAmended
Kiley Alison
Director10% Owner
Transactions
- Purchase
Common Stock
2010-10-27$9.50/sh+315,789$2,999,996→ 2,680,551 total(indirect: See Footnotes)
Footnotes (3)
- [F1]This amendment is being filed to correct a typographical error in the amount of securities beneficially owned following all reported transactions and reported in Column 5 of Table I from 2,860,551 shares to 2,680,551 shares.
- [F2]The Reporting Person is a member of Alta BioPharma Management III, LLC ("ABMIII"), which is the general partner of Alta BioPharma Partners III, L.P. ("ABPIII") and the managing limited partner of Alta BioPharma III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). She may be deemed to share investment power over the securities of the Issuer held by ABPIII, ABPIIIKG and Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII") with the directors of ABMIII and managers of AEBPIII but disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein.
- [F3]ABPIII acquired 289,236 shares of common stock in the Issuer's public offering, ABPIIIKG acquired 19,425 shares of common stock in the Issuer's public offering and AEBPIII acquired 7,128 shares of common stock in the Issuer's public offering. All shares were purchased at the initial public offering price of $9.50 per share.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeother
Related Parties
1- filerCIK 0001341637
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 3:47 PM ET
- Size
- 6.5 KB